---
figid: PMC9027317__marinedrugs-20-00225-g006
pmcid: PMC9027317
image_filename: marinedrugs-20-00225-g006.jpg
figure_link: /pmc/articles/PMC9027317/figure/marinedrugs-20-00225-f006/
number: Figure 6
figure_title: ''
caption: 'Effects of fucoxanthin on the levels of interleukin (IL)-1β (A), IL-6 (B)
  and tumor necrosis factor-α (TNF-α) (C) in FFA-treated liver cells. Data are expressed
  as mean ± standard deviation (n = 3), ** p < 0.01 vs. control group, ## p < 0.01
  vs. FFA group.'
article_title: Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver
  Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4
  Signaling Pathway.
citation: Jiena Ye, et al. Mar Drugs. 2022 Apr;20(4):225.
year: '2022'

doi: 10.3390/md20040225
journal_title: Marine Drugs
journal_nlm_ta: Mar Drugs
publisher_name: MDPI

keywords:
- NAFLD
- fucoxanthin
- adenosine monophosphate-activated protein kinase (AMPK)
- nuclear factor erythroid-2-related factor 2-mediated (Nrf2)
- Toll-like receptor 4-mediated (TLR4)

---
